Study of Satraplatin (JM-216) in Combination With Docetaxel

PHASE1TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Tumors
Interventions
DRUG

satraplatin and docetaxel

"Satraplatin - oral administration within 2 hours of docetaxel infusion. Subsequent dosing will be on days 2-5 at approximate 24 hour intervals.~Docetaxel will be administered as intravenous infusion over 1 hour followed by saline flush."

Trial Locations (1)

53792

University of Wisconsin Comprehensive Cancer Center, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Agennix

INDUSTRY

NCT00125411 - Study of Satraplatin (JM-216) in Combination With Docetaxel | Biotech Hunter | Biotech Hunter